<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24770512</article-id>
      <article-id pub-id-type="pmc">4008066</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20142857</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Arthritis and diagnosis of leprosy: a case report and review of the
literature<sup><xref ref-type="fn" rid="fn01">*</xref></sup>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fernandes</surname>
            <given-names>Tania Rita Moreno de Oliveira</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Korinfskin</surname>
            <given-names>Juliana Pedrosa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Esp&#xED;ndola</surname>
            <given-names>Mariana Merc&#xEA;s Mesquita</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Corr&#xEA;a</surname>
            <given-names>Lis Moreno de Oliveira</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Universidade Federal do Vale do S&#xE3;o Francisco (Univasf) - Petrolina
(PE), Brazil. </aff>
      <aff id="aff02"><label>2</label>Universidade Federal da Bahia (UFBA) - Salvador (BA), Brazil. </aff>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Tania Rita Moreno de Oliveira Fernandes, Av. Jos&#xE9; de
S&#xE1; Mani&#xE7;oba, s/n - Centro, 56304-205 - Petrolina - PE, Brazil. E-mail:
<email>trmofernandes@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>2</issue>
      <fpage>323</fpage>
      <lpage>325</lpage>
      <history>
        <date date-type="received">
          <day>09</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>8</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Leprosy is clinically characterized by involvement of peripheral nerves and skin. The
immunological profile of the individual defines the diversity of clinical
manifestations, from skin disorders to systemic manifestations, especially the
articulation ones, common in multibacillary forms, which may mimic collagen diseases
and often posing diagnostic difficulties in endemic areas. This is a case report of
asymmetric polyarthritis of small and large articulations associated with skin
lesions which had been treated by a rheumatologist for 2 years with initial clinical
diagnosis of rheumatoid arthritis, and later, with the appearance of skin lesions, of
systemic lupus erythematosus.</p>
      </abstract>
      <kwd-group>
        <kwd>Arthritis</kwd>
        <kwd>Erythema nodosum</kwd>
        <kwd>Leprosy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Hansen's disease (HD) is one of the main public health problems in Brazil (a country
that has the largest number of cases in Latin America and the second worldwide),
according to the World Health Organization (WHO).<sup><xref rid="r01" ref-type="bibr">1</xref></sup> Its etiological agent is <italic>Mycobacterium leprae</italic> and
its infection source is the individual without treatment. A systemic disease, the
bacillus enters the body through the upper airways, migrates through the hemolymphatic
system to the reticuloendothelial system organs and lodges itself in the cutaneous nerve
branches and peripheral nerve trunks. On these locations the amount of bacilli and the
host's immune response determine the evolution and the disease's clinical
form.<sup><xref rid="r02" ref-type="bibr">2</xref></sup> Ridley and Joplin defined
Hansen's disease as a spectral disease. At one end the localized or tuberculoid form
(THD), associated with type Th1 immunologic response (cellular), and at the other the
virchowian form (VHD), systemic, of type Th2 immunologic response (humoral); at the
central part of this are the Dimorphic (DHD) or borderline forms.<sup><xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>Clinically it presents from skin lesions with insensitivity areas to severe neural
lesions and systemic involvement typical of multibacillary forms (MBHD), DHD and VHD. In
its insidious evolution or during reactional episodes symptoms like fever, fatigue,
paresthesias, myalgias occur, which in association with cutaneous and visceral lesions
make it similar to collagenosis and other systemic diseases.<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>We report a case of asymmetric polyarthritis of small and large articulations associated
with cutaneous lesions, which had been treated for 2 years by a rheumalogist, with
initial diagnostic suspicion of rheumatoid arthritis (RA), and afterwards, due to the
onset of cutaneous lesions of Systemic Lupus Erythemathosus (SLE).</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p><bold>Clinical History:</bold> A 65 year-old, White female, homemaker, born and from
juazeiro-Bahia-Brazil, presenting for approximately two years pain and swelling on her
left metatarsoplalangeal and right metacarpophalangeal articulations, that progressively
evolved to the right foot, left hand, ankles and wrists. She consulted several
orthopedists being medicated with prednisone and nonsteroidal anti-inflammatories
(NSAIDs), and was referred to a rheumatologist, that diagnosed her as RA and continued
prednisone and NSAIDs. In continuous use of prednisone (20mg/dar), she presented
erythematous nodules on face, upper and lower limbs, paresthesia on feet and hands, and
worsening of articular pain and edema, being diagnosed as SLE, and continued the
treatment with prednisone associated with clonazepam. A few days latter, she presented
fever, worsening of the lesions and articular pain, being hospitalized and diagnosed as
eruptions induced by drugs and RA, and referred for a dermatologist.</p>
      <p><bold>Complementary Exams</bold> (brought by patient): Liver and kidney function tests,
C-reactive protein, protein electrophoresis, VDRL, ANF, urinalysis, glycemia, normal.
High sedimentation rate - 19mm in the 1<sup>st</sup> hour and leukogram of 14,900 with
46 lymphocytes (up to 39).</p>
      <p><bold>Clinical Exam:</bold> Skin: erythematous-purplish plaques, erythematous papules
and nodules, on face, trunk and UL and LL, face infiltration, fifth finger of R hand in
moving claw, edema on hands and feet (<xref ref-type="fig" rid="f01">Figures 1</xref>,
<xref ref-type="fig" rid="f02">2</xref> and <xref ref-type="fig" rid="f03">3</xref>).
As there was diagnostic suspicion of VHD, an AARB search in lymph smear was requested,
which resulted positive - bacterial index 3.5 (<xref ref-type="fig" rid="f04">Figure
4</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Erythematous nodules on thighs. Hand with edema and erythema. Fifth finger in
moving claw</p>
        </caption>
        <graphic xlink:href="abd-89-02-0323-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Erythematous nodules on face</p>
        </caption>
        <graphic xlink:href="abd-89-02-0323-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Edema on both feet</p>
        </caption>
        <graphic xlink:href="abd-89-02-0323-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Intradermal smear with alcohol-acid resistant bacillus, single and in small
groups</p>
        </caption>
        <graphic xlink:href="abd-89-02-0323-g04"/>
      </fig>
      <p><bold>Diagnosis:</bold> VHD with type II reaction</p>
      <p><bold>Conduct:</bold> Polychemotherapy (PCT) initiated associated with Prednisone
(60mg/day) and Thalidomide 200mg/day.</p>
      <p><bold>Evolution:</bold> 7 days after beginning of treatment the patient presented
improvement of cutaneous lesions and arthralgias; 30 days after improvement of
paresthesia and after 60 days almost complete regression of cutaneous and articular
lesions (<xref ref-type="fig" rid="f05">Figures 5</xref> and <xref ref-type="fig" rid="f06">6</xref>).</p>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Edema regression on feet 2 months after start of treatment</p>
        </caption>
        <graphic xlink:href="abd-89-02-0323-g05"/>
      </fig>
      <fig id="f06" orientation="portrait" position="float">
        <label>FIGURE 6</label>
        <caption>
          <p>Regression of lesions on face 2 months after treatment</p>
        </caption>
        <graphic xlink:href="abd-89-02-0323-g06"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>HD must always be considered among the differential diagnoses of arthritides in endemic
regions. In the literature, there are descriptions of patients with HD that were
diagnosed with SLE, RA, dermatopolymyositis and systemic vasculitides.<sup><xref rid="r05" ref-type="bibr">5</xref></sup> These manifestations occur mainly in
MBHD, in reactional episodes and arise from infiltration and direct proliferation of the
bacillus in the affected organ.<sup><xref rid="r05" ref-type="bibr">5</xref></sup>
According to Pernambuco et al, polyarthritis may be an initial symptom of HD and the
articular manifestations that occur during reactional episodes in HD make it similar to
collagenoses.<sup><xref rid="r06" ref-type="bibr">6</xref></sup> Arthritides of
large and small articulations occur, usually symmetrical. On type 1 reverse reaction
(RR) as opposed to Erythema Nodosum Leprosum (ENL) there are no general symptoms or
fever and alterations are localized. Arthritis usually occurs underlying the cutaneous
lesions.<sup><xref rid="r06" ref-type="bibr">6</xref></sup> The onset of
polyarthritis is insidious and progressive, similar to RA. In ENL arthropathy is
presented in several ways; the polyarticular form in small and large articulations,
similar to RA, is the most common. It appears concomitantly with the cutaneous lesions,
but may precede them.<sup><xref rid="r07" ref-type="bibr">7</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>The symptoms of fever, fatigue, paresthesias and musculoskeletal complaints, associated
with the dermatological lesions and visceral involvement, contribute to the similarity
between HD and several other infectious pathologies or connective tissue diseases.
Clinical and laboratory alterations present in SLE, in dermatomyositis (DM) and in RA
are present in VHD: arthritis, malar rash, vasculitis, myalgia and myositis,
lymphopenia, antinuclear factor (ANF), antiphospholipid antibodies, rheumatoid factor,
anticardiolipin antibodies and ANCA, among others.<sup><xref rid="r10" ref-type="bibr">10</xref></sup> In ENL, exams like ANF and latex may be altered in 30% of the
cases. In the present case the erythrocyte sedimentation rate and CRP are normal for the
patient's age, which occurred as a result of long-term corticotherapy undergone by the
patient. Infectious diseases are part of differential diagnosis of rheumatic diseases in
endemic environments, while a superimposition of clinical and laboratory alterations is
possible. The physician, the rheumatologist and the dermatologist should employ
auxiliary means like bacilloscopy and cutaneous biopsy for diagnostic elucidation.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Fernandes TRMO, Korinfskin JP, Esp&#xED;ndola MMM, Correa LMO.
Arthritis and diagnosis of leprosy: a case report and review of the literature. An
Bras Dermatol. 2014;89(2):323-5.</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Work performed at Universidade Federal do Vale do S&#xE3;o Francisco (UNIVASF) - Petrolina
(PE), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Who.int</collab>
          </person-group>
          <comment>[homepage on the Internet]</comment>
          <source>Prevalence of leprosy at start of 2011</source>
          <date-in-citation content-type="access-date">cited 2013 Apr 28</date-in-citation>
          <comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/lep/situation/prevalence/en/#">http://www.who.int/lep/situation/prevalence/en/#</ext-link></comment>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prevedello</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>T&#xE1;vora</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Leprosy: a genetic disease?</article-title>
          <source>An Bras Dermatol</source>
          <year>2007</year>
          <volume>82</volume>
          <fpage>451</fpage>
          <lpage>459</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freitas</surname>
              <given-names>D S</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Andrigueti</surname>
              <given-names>FV</given-names>
            </name>
            <name>
              <surname>Reis</surname>
              <given-names>ET</given-names>
              <suffix>Neto</suffix>
            </name>
            <name>
              <surname>Pinheiro</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <article-title>Lepromatous leprosy associated with the use of anti-TNF &#x3B1; therapy:
case report</article-title>
          <source>Rev Bras Reumatol</source>
          <year>2010</year>
          <volume>50</volume>
          <fpage>333</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="pmid">21125169</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>SLE</given-names>
            </name>
            <name>
              <surname>Guedes</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>HLA</given-names>
            </name>
            <name>
              <surname>Souza</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Manifesta&#xE7;&#xF5;es sist&#xEA;micas e ulcera&#xE7;&#xF5;es cut&#xE2;neas da
hansen&#xED;ase: diagn&#xF3;stico diferencial com outras doen&#xE7;as reum&#xE1;ticas</article-title>
          <source>Rev Bras Reumatol</source>
          <year>2009</year>
          <volume>49</volume>
          <fpage>623</fpage>
          <lpage>629</lpage>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Freire</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Carneiro</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Teodoro</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Cecin</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Manifesta&#xE7;&#xF5;es Reum&#xE1;ticas na hansen&#xED;ase: dificuldades no
diagn&#xF3;stico precoce</article-title>
          <source>Rev Bras Reumatol</source>
          <year>1998</year>
          <volume>38</volume>
          <fpage>210</fpage>
          <lpage>214</lpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pernambuco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pernambuco</surname>
              <given-names>JCA</given-names>
            </name>
            <name>
              <surname>Ura</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fleury</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Hansen&#xED;ase Virchoviana e artrite reumat&#xF3;ide:
sobreposi&#xE7;&#xE3;o ou mimetismo?</article-title>
          <source>Hansen Int</source>
          <year>2002</year>
          <volume>27</volume>
          <fpage>29</fpage>
          <lpage>34</lpage>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Veradino</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Presoto</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Carneiro</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Comprometimento osteo-articular na
hansen&#xED;ase</article-title>
          <source>Rev Hosp Univ Pedro Ernesto</source>
          <year>2011</year>
          <volume>10</volume>
          <fpage>45</fpage>
          <lpage>48</lpage>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereira</surname>
              <given-names>HLA</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>SLE</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>EI</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Manifesta&#xE7;&#xF5;es reum&#xE1;ticas da hansen&#xED;ase</article-title>
          <source>Acta Reumatol Port</source>
          <year>2008</year>
          <volume>33</volume>
          <fpage>407</fpage>
          <lpage>414</lpage>
          <pub-id pub-id-type="pmid">19078860</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pereira</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Pennini</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>EI</given-names>
            </name>
          </person-group>
          <article-title>Leprosy-related joint involvement</article-title>
          <source>Clin Rheumatol</source>
          <year>2009</year>
          <volume>28</volume>
          <fpage>79</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">18807102</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teixeira</surname>
              <given-names>GJ</given-names>
              <suffix>Junior</suffix>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Magalh&#xE3;es</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Application of the diagnostic criteria for systemic lupus
erythematosus to patients with multibacillary leprosy</article-title>
          <source>Rev Soc Bras Med Trop</source>
          <year>2011</year>
          <volume>44</volume>
          <fpage>85</fpage>
          <lpage>90</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
